The female germ cell stage of primary importance in radiation genetic hazards is the immature, arrested oocyte. In the mouse, this stage has a near zero or zero sensitivity to mutation induction by radiation. However, the application of these mouse results to women has been questioned on the ground that the mouse arrested oocytes are highly sensitive to killing by radiation, while the human cells are not; and, furthermore, that the mature and maturing oocytes in the mouse, which are resistant to killing, are sensitive to mutation induction. The present results have a 2-fold bearing on this problem. First, a more detailed analysis of oocyte-stage sensitivity to killing and mutation induction shows that there is no consistent correlation, either negative or positive, between the two. This indicates that the sensitivity to cell killing of the mouse immature oocyte may not be sufficient reason to prevent its use in predicting the mutational response of the human immature oocyte. Second, if the much more cautious assumption is made that the human arrested oocyte might be as mutationally sensitive as the most sensitive of all oocyte stages in the mouse, namely the maturing and mature ones, then the present data on the duration of these stages permit more accurate estimates than were heretofore possible on the mutational response of these stages to chronic irradiation.
correlation, either negative or positive, between the two. This indicates that the sensitivity to cell killing of the mouse immature oocyte may not be sufficient reason to prevent its use in predicting the mutational response of the human immature oocyte. Second, if the much more cautious assumption is made that the human arrested oocyte might be as mutationally sensitive as the most sensitive of all oocyte stages in the mouse, namely the maturing and mature ones, then the present data on the duration of these stages permit more accurate estimates than were heretofore possible on the mutational response of these stages to chronic irradiation. Because no transmitted genetic effects of radiation have been clearly detected in man, estimates of human genetic hazards from radiation are necessarily based on experimental animals, primarily the mouse. No special difficulties have been seen in extrapolating data from the male mouse. In applying the female mouse data to the human, however, there is a potential problem. The present paper deals with one aspect of this problem.
The female germ cell stage of primary importance in radiation genetic hazards is the immature, arrested oocyte. In most of the conceptions in women who have had a prior exposure to radiation, most of the dose will have been accumulated in this oocyte stage. In 1965, the surprising discovery was reported (1) that, although the mature oocyte in the mouse is highly sensitive to mutation induction, the immature arrested oocyte appears to be completely resistant. This was shown first for acute neutron irradiation, but the finding was later extended to acute x-irradiation and chronic y irradiation. The results from eight separate experiments, summarized in a review paper (2) , gave a total of 259,683 offspring from conceptions that occurred more than 7 weeks after irradiation of the mother. These conceptions involved oocytes that had received their radiation exposure in the immature arrested stage or, shortly after, in the beginning stages of follicle development. Only three mutations were detected by using our standard test for mutation induction at seven specific loci (3) . This is slightly, but not, of course, significantly below the control (spontaneous) mutation frequency at the same seven loci, the latest totals for
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which are shown in Table 1 . Thus, the mouse immature arrested oocyte shows no evidence of mutation induction, even after doses as high as 60 rads of neutrons and 400 roentgens (R) of y rays.
(1 rad = 10-2 j/kg; 1 R = 2.6 X IO-4 C/kg).
Since this discovery, committees charged with the responsibility for estimating genetic hazards of radiation have tended to regard the induced mutation frequency in women as negligible compared to that in men. However, as this author (2) and others have pointed out, and as the committees have recognized, the immature oocytes of the mouse, though resistant to mutation induction, are highly sensitive to killing by radiation, whereas human immature oocytes are resistant to killing. There are also species differences in the cytological appearance of the arrested oocytes. Thus, the question arises as to whether it is valid to assume that the human arrested oocyte will, like that of the mouse, be resistant to mutation induction.
Our approach to this problem has been to investigate the mutational response of other oocyte stages in the mouse, including the maturing and mature ones, which are resistant to killing by radiation. These stages are highly mutationally sensitive to acute, high-dose-rate irradiation, but have proved to be insensitive to low-dose-rate irradiation. Furthermore, at low doses of high-dose-rate irradiation the mutation frequency drops well below that expected on a linear relationship with dose. Therefore, we have concluded that mouse oocyte stages covering a wide range of sensitivity to killing will, under the usual conditions of human exposure, show a low or zero mutation frequency (2) .
The latest, 1972, reports of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) (5) and the U.S. National Academy of Sciences Committee on the Biological Effects of Ionizing Radiations (BEIR) (6) adopted a similar view. The mutational response of the mouse arrested oocyte was taken as zero or near zero, and the mutational sensitivity of the mouse maturing and mature oocytes to chronic irradiation was computed to be only about 1/20 of that to acute irradiation.
Since the publication of these reports, Lyon and Phillips (7) have collected a most valuable set of data which support and extend the conclusions reached from the earlier results. In contrast, the interpretation of the earlier work has been challenged by Wolff (8) and Abrahamson and Wolff (9) . In two papers, containing essentially the same material, they attempt to explain the mouse specific-locus mutation data on the basis of an old mathematical model for two-break chromosome aberration induction. In order to make the data fit this model, they have assumed a duration of oocyte stage sensitivity which, as the present paper will show, is inconsistent with the facts, and they have concluded from this that the mutational sensitivity of the maturing and mature mouse oocytes to chronic irradiation is much greater than had been supposed. The present paper, in addition to providing new data on spontaneous mutations, analyzes, in more detail than heretofore, the results of low-level irradiation of maturing oocytes, including the new data of Lyon and Phillips. It also discusses the interpretation of Abrahamson and Wolff, and presents some hitherto unpublished information on the distribution of mutations with time after irradiation that has an important bearing on the discussion.
RESULTS AND DISCUSSION
One of the difficulties in measuring the effect of low-dose-rate irradiation on mutation frequency in maturing oocytes is that the length of radiation exposure time necessary to accumulate a sizable dose may approach the duration of the oocyte stage under measurement. For example, suppose we want to determine the mutation frequency from chronic irradiation of maturing oocytes that are not more than 6 weeks from ovulation. Giving a dose of 258 R took 3 weeks. Therefore, any conceptions occurring more than 3 weeks after the end of irradiation would involve oocytes that received part of their dose earlier than 6 weeks before ovulation. When we discovered that the mutation frequency drops apparently to zero for conceptions occurring more than 6 or 7 weeks after irradiation (1) , it was immediately apparent, and was pointed out at that same time, that the lowness of a total mutation frequency in offspring collected from a 6-week mating period after the end of irradiation could have resulted partly from a low-dose-rate effect on maturing oocytes and partly from a portion of the dose having been given to the oocytes in immature stage, more than 6 weeks before conception. However, as was shown long before that, at the beginning of our dose-rate studies in females, a very low mutation frequency from chronic irradiation could be demonstrated for comparisons restricted to conceptions occurring within 2 weeks after accumulation of the dose (10) .
In order to utilize data collected from conceptions occurring more than 3 weeks after irradiation, in this example, it is necessary to compute the portion of the dose received in the effective period. This was done, but not published, in a rather crude way in computations used to arrive at the figure of 1/20 which, as was mentioned earlier, was accepted by the UN-SCEAR and BEIR committees as the ratio of effects of chronic to acute irradiation in maturing oocytes. With additional data from Lyon and Phillips (7) now available, and with the mutation frequencies challenged by Abrahamson and Wolff (9) , it now seems desirable to make more precise estimates.
In order to do this, it was necessary to determine as sharply as possible the time interval after irradiation at which mutation frequency dropped. It was also necessary to find out if this was a sudden drop or a gradual one spread over several weeks. Pertinent data from our experiments are collected in Table 2 Table 2 and other data it also appears that offspring conceived in the first week after irradiation have a lower mutation frequency than those conceived during weeks 2 to 6 after irradiation. This will -be discussed in another paper.
With this information, it is now possible to compute an "effective dose" for offspring conceived within 6 weeks after the end of a period of chronic irradiation. By "effective dose" is meant the portion of the total dose that will have been received 6 weeks or less before ovulation.
As an example of the computation, we can pick one that happened to work out in simple fashion, namely, the 400-R experiment, in which the dose was given at approximately 0.009 R/min over a period of 35 days. Offspring from conceptions that occurred in the first week after the end of irradiation came from oocytes that received all of their dose in less than 6 weeks before ovulation. For animals conceived in the second week the average dose received by the oocytes in the 6 weeks before ovulation turns out to be 90% of the total 400 R, or 360 R. For the third week it is 70%, or 280 R, and so on. In the sixth week it is only 40 R. By weighting these doses by the number of ani- Table 3 . Table 3 are plotted in Fig. 1 Table  3 , and theoretical fits by Abrahamson and Wolff (8) . See Abrahamson and Wolff, on the one hand, admit that their corrections for effective dose are crude, but, on the other hand, conclude "it is reasonable to assume" that the wide discrepancies between their theoretical expectations and the actual data are "caused by some of the radiation occurring during less mutable stages." Because the data shown in Fig. 1 have already been adjusted for this factor by our criteria, it is of interest to see how much discrepancy is still left between the corrected observed values and the Abrahamson-Wolff prediction.
The two values of a for the fits preferred by Abrahamson and Wolff are shown in Fig. 1 (5, 6) , accepted 1/20 as the ratio of mutation rate from chronic irradiation to that from acute irradiation. The rates presented in this paper (slopes a, b, c, and d in Fig. 1 ) for low-level irradiation of mature and maturing oocytes, when compared to the mutation rate for our 400-R acute irradiation data (ref. 15 , and unpublished), yield ratios of 1/18, 1/29, 1/24, and 1/46, respectively. The true ratios would be expected to be even somewhat lower, because the 400-R acute irradiation data contain a higher proportion of offspring from oocytes that received all of their radiation in the week before ovulation, when the mutational sensitivity is lower than for radiation received from 2 to 6 weeks before ovulation. In any case, with the more precise estimation of the effective doses than was available to the committees, and with the addition of the new data of Lyon and Phillips (7), it turns out that the committees' statements did not underestimate the risks from low-level irradiation of mature and maturing oocytes.
It is of interest to compare the specific-locus mutation rates obtained for mature and maturing oocytes with the mutation rate in the male mouse for chronic irradiation of the germ-cell stage primarily at risk in human hazards, namely, the spermatogonia. The mutation rate, for the same seven loci, in mouse spermatogonia irradiated at dose rates of 0.009 R/min and below, was calculated in the review paper by Searle (16) to be 6.59 X 10-8 per locus, per R. The rates for low-level irradiation of mature and maturing oocytes (slopes a, b, c, and d in Fig. 1 2, than for the less mature oocytes that pkoduced thbfig listed for weeks 2 to 6. The fully mature oocytes are less siiive to killing than the less mature ones. Thus, here there is a positive correlation between killing and mutational sensitivity. This is in contrast to the negative correlation found for immature arrested oocytes, which give no evidence of mutation induction but which are highly sensitive to killing. It appears, from the lack of consistent correlation, that mutation induction and killing are independent events. In this connection, the new data of Cox and Lyon (17) on x-ray induction of dominant lethal mutations in mature and immature oocytes of guinea pigs and golden hamsters are of great importance. In both species, they found lower mutation yields from immature than from mature oocytes, despite the fact that the immature oocytes of the guinea pig are less sensitive to killing than the mature ones, while the reverse is true for the golden hamster, which, therefore, resembles the mouse.
Thus again, as the authors state, there is "no general pattern ... of correlation, either positive or negative, in the sensitivity of oocytes to killing and to dominant lethal induction." This is in contrast to the statement by Abrahamson (18) that "I suspect that cell killing, chromosome rearrangements and gene mutations are rather closely linked." The fact that cell killing of oocytes is apparently not linked to the other two effects is not surprising to us. Death of the cells occurs rapidly, before cell division, and is, therefore, not related to the kind of death that results from aneuploidy after cell division.
Cox and Lyon question whether dominant lethals and gene mutations behave similarly, but their doubts are based on the fact that Searle and Beechey (19) had shown an increase in dominant-lethal frequency over the first 3 weeks after irradiation of female mice. Cox and Lyon believed that this disagreed with the gene mutation results, because they were aware only of the decline in mutation frequency with time after irradiation. However, there is no disagreement: the decline in gene mutation frequency occurs only after 6 weeks, and, with the new data reported in Table 2 , it is now clear that, as with dominant lethals, there is, in fact, an increase in gene mutation frequency after the first week.
In summary, there would now seem to be less reason than before for rejecting an application of the mouse immature arrested oocyte data to the human immature arrested oocyte. In the immature oocytes, the specific-locus mutation frequency and X-chromosome loss frequency (20) in the mouse and the dominant lethal frequency in guinea pig and golden hamster are all low compared to the frequencies in mature oocytes. The fact that this is so, despite the differences in sensitivity to cell killing, and in chromosomal morphology, in the immature oocytes of these species, indicates that the sensitivity to cell killing of the mouse immature oocyte may not be sufficient reason to prevent its use in predicting the mutational response of the human immature oocyte.
If, on the side of caution, one continues to consider the possibility that the human immature arrested oocyte might be as mutationally sensitive as the most sensitive of all oocyte stages in the mouse, namely the maturing and mature oocytes, then the present paper provides estimates for this extrapolation. With low-level irradiation, the estimates of mutational frequency in these stages average from 0.17 to 0.44 times that in spermatogonia, but in three of the four estimates the frequencies are not significantly above control values. Thus, even in the event that the response of the human immature arrested oocyte is unlike that of the mouse arrested oocyte, but similar to that of the most monsltive oocyte stages in the mouse, it seems likely that the genetic hazard of radiation in the female will still be less than in the male. For 
